Insider trades

Ran Nussbaum, Director of LB Pharmaceuticals LBRX, has filed 1 purchase and 4 sales on the open market. Over the past 12 months that comes to a net sale of $85M. The latest trade was on 06/03.

Ran Nussbaum

Director
First filing
23/02/28
Trades
20 trades
Buys / sales
1 / 4
12-month net buying
−$85M
Last trade
06/03

Trading activity

Transactions

Trade type
KROS
Open-market sale25/10/1525/10/174,787,331 sh4 trades$17.75avg.$84,975,125.25−100.0%
Open-market buy25/09/1225/09/161,000,000 sh$15.00$15,000,000+242.9%